In Brief: Possis
This article was originally published in The Gray Sheet
Executive Summary
Possis: Gains CE Mark approval for the AngioJet rapid thrombectomy system for peripheral applications and the Perma-Seal dialysis access graft. CE mark approval is pending for coronary applications of the AngioJet System and for the Perma-Flow coronary bypass graft. The AngioJet was cleared by FDA in December 1996 and a 510(k) for the Perma-Seal is pending at FDA ("The Gray Sheet" June 17, 1996, In Brief)...